BIOL

Q: What is the price of BIOLASE (BIOL) today?

The current price of BIOLASE (BIOL) is $ 0.00, representing a 0% gain over the past year. The stock began the year trading around $ 0.00 and is currently priced at $ 0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does BIOLASE (BIOL) pay dividends?

BIOLASE (BIOL) did not pay dividends over the past year.

Q: Is BIOLASE (BIOL) a good investment?

BIOLASE (BIOL) is currently trading at $ 0.00 with a P/E ratio of -0.12%. This represents a -589% premium compared to its historical average P/E. Over the past year, the stock has gained 0 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 0.00%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

BIOLASE Inc.

Price

$ -

return (12m)

0.00%

p/e

-0.12

p/bv

-0.51

DIVIDEND YIELD

0.00%

BIOL price

BIOL

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment BIOL

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals BIOL

review the fundamentals of BIOLASE shares

P/E

-0.12

Sector: -2.28 Industry: 49.51

P/S (PSR)

0.05

Sector: 1.95 Industry: 5.57

P/BV

-0.51

Sector: 2.14 Industry: 12.47

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: 2.04%

ROA

-62.69%

Sector: -26.12% Industry: 5.67%

ROE

443.63%

Sector: -29.95% Industry: 12.35%

ROIC

-55.62%

Sector: -417.03% Industry: 15.75%

NET MARGIN

-41.68%

Sector: -28.23% Industry: 12.69%

GROSS MARGIN

33.01%

Sector: 44.62% Industry: 88.92%

OPERATING MARGIN

-35.86%

Sector: -23.34% Industry: 29.80%

EV/EBITDA

-0.15

Sector: -0.65 Industry: 29.98

EV/EBIT

-0.13

Sector: -1.83 Industry: 48.57

PRICE-TO-ASSETS

0.07

Sector: 1.15 Industry: 2.78

BVPS

-0.13

Sector: 3.73 Industry: 32.11

EPS

-0.58

Sector: -0.90 Industry: 3.55

EQUITY-TO-ASSETS RATIO

-0.14

Sector: 0.43 Industry: 0.69

LIABILITIES / ASSETS

-0.14

Sector: 0.46 Industry: 0.79

CAGR REVENUE 5 YEARS

3.30%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

2.83%

Sector: - Industry: -

Fundamentals BIOL

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
ISRG	57.46	9.73	16.93%	0.00%	$ 171.19 B	28.15%
TMO	25.52	3.36	13.15%	0.37%	$ 174.73 B	15.15%
SNY	12.52	1.36	10.86%	4.73%	$ 114.19 B	18.68%
ABT	25.14	0.00	0.00%	2.64%	$ 157.79 B	13.91%
MDT	23.17	2.17	9.38%	3.41%	$ 106.90 B	13.00%
CVS	55.99	1.31	2.35%	3.41%	$ 98.98 B	0.44%
BSX	25.86	0.00	0.00%	0.00%	$ 92.17 B	17.29%
TMDX	19.82	7.97	40.22%	0.00%	$ 3.77 B	31.43%
HCA	14.26	-32.53	-228.14%	0.68%	$ 96.87 B	8.89%
IDXX	42.73	28.20	65.99%	0.00%	$ 45.27 B	24.62%
DHR	34.02	2.37	6.97%	0.77%	$ 125.49 B	14.89%
INMD	9.67	1.33	13.73%	0.00%	$ 907.20 M	25.32%
PHG	25.18	2.03	8.06%	3.23%	$ 26.12 B	5.07%
SYK	38.64	5.59	14.48%	1.04%	$ 125.44 B	12.92%
FMS	11.54	0.78	6.75%	3.46%	$ 13.02 B	5.02%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*The value considers the reinvestment of dividends.

BIOL Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	06/28/2005	07/12/2005	114,84972458
Dividends	04/25/2005	05/09/2005	114,84972458
Dividends	02/10/2005	02/24/2005	114,84972458
Dividends	12/15/2004	12/29/2004	114,84972458
Dividends	10/13/2004	10/27/2004	114,84972458
Dividends	08/16/2004	08/30/2004	114,84972458

ABOUT BIOLASE

BIOLASE Inc.

Average Investor10 user rating

4.0 (1 people)

United States

39 years

Founded: 1987

1992

Time since IPO - 34 years

135

Employees

BIOLASE Inc. (United States) is listed on the Nasdaq and has a market capitalization of $2.22 Millions, with shareholders equity totaling $-4.33 Millions.

The company employs approximately 135 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, BIOLASE Inc. reported $46.09 Millions in revenue, generating net income of $-19.21 Millions.

Key financial metrics include a P/E ratio of -0.12, a price-to-book (P/B) ratio of -0.51, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker BIOL.

Market cap

$ 2.22 Millions

Net worth

$ -4.33 Millions

$ -4,330,000.00

Assets

$ 30.64 Millions

$ 30,640,000.00

Total Shares Outstanding

33.00 Millions

33,000,000

Average Daily Trading Volume

$ 132.23 Thousand

$ 132,229.90

Sector

Health

Industry

Medical Supplies and Equipment

BIOL

BIOL revenue and profits

Financial Results BIOL

DRAG THE FRAME TO SEE MORE DATA

BIOL cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 82.09 26,14% (12M)

P/E

55.99

3.41%

ROE

2.35%

P/BV

1.31

HCA - HCA Healthcare

$ 433.09 25,31% (12M)

P/E

14.26

0.68%

ROE

-228.14%

P/BV

-32.53

ABT - Abbott

$ 89.46 --30,95% (12M)

P/E

25.14

2.64%

ROE

0.00%

P/BV

0.00

TMO - Thermo Fisher Scientific

$ 469.21 11,19% (12M)

P/E

25.52

0.37%

ROE

13.15%

P/BV

3.36

MDT - Medtronic

$ 80.00 --2,72% (12M)

P/E

23.17

3.41%

ROE

9.38%

P/BV

2.17

TAK - Takeda Pharmaceutical

$ 16.63 13,52% (12M)

P/E

69.74

3.98%

ROE

1.54%

P/BV

1.07

SYK - Stryker

$ 294.73 --21,32% (12M)

P/E

38.64

1.04%

ROE

14.48%

P/BV

5.59

LBPSW - 4D pharma

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-300.00%

P/VP

0.00

CVS - CVS Health

$ 82.09 26,14% (12 M)

P/L

55.99

3.41%

ROE

2.35%

P/VP

1.31

HCA - HCA Healthcare

$ 433.09 25,31% (12 M)

P/L

14.26

0.68%

ROE

-228.14%

P/VP

-32.53

ABT - Abbott

$ 89.46 --30,95% (12 M)

P/L

25.14

2.64%

ROE

0.00%

P/VP

0.00

TMO - Thermo Fisher Scientific

$ 469.21 11,19% (12 M)

P/L

25.52

0.37%

ROE

13.15%

P/VP

3.36

MDT - Medtronic

$ 80.00 --2,72% (12 M)

P/L

23.17

3.41%

ROE

9.38%

P/VP

2.17

TAK - Takeda Pharmaceutical

$ 16.63 13,52% (12 M)

P/L

69.74

3.98%

ROE

1.54%

P/VP

1.07

SYK - Stryker

$ 294.73 --21,32% (12 M)

P/L

38.64

1.04%

ROE

14.48%

P/VP

5.59

Frequently Asked Questions

What is the price of BIOLASE (BIOL) today?

The current price of BIOLASE (BIOL) is $ 0.00, representing a 0% gain over the past year. The stock began the year trading around $ 0.00 and is currently priced at $ 0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does BIOLASE (BIOL) pay dividends?

BIOLASE (BIOL) did not pay dividends over the past year.

Is BIOLASE (BIOL) a good investment?

BIOLASE (BIOL) is currently trading at $ 0.00 with a P/E ratio of -0.12%. This represents a -589% premium compared to its historical average P/E. Over the past year, the stock has gained 0 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy BIOLASE (BIOL) stock?

You can buy BIOLASE (BIOL) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol BIOL and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of BIOLASE (BIOL) yield today?

Over the past month, BIOLASE (BIOL) has returned 0.00% — 0.00% over the past year, and 0.00% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of BIOLASE (BIOL) today at the current price of $ 0.00 your total investment would be $ 0.00.

Based on historical performance, the investment would have grown to approximately:

$ 0.00 after 1 year
$ 0.00 after 5 years
$ 0.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

BIOL

BIOLASE Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment BIOL

review the fundamentals of BIOLASE shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

current DY: 0.00%

5-year average DY: 0.00%

type

Ex - Dividend Date

payment date

value

ABOUT BIOLASE

BIOLASE Inc.

United States

39 years

1992

135

PROFIT X PRICE BIOL

Financial Results BIOL

BIOL cash flow

Asset, Revenue and Profit Growth - BIOL

BIOL balance sheet

LBPSW - 4D pharma

CVS - CVS Health

HCA - HCA Healthcare

ABT - Abbott

TMO - Thermo Fisher Scientific

MDT - Medtronic

TAK - Takeda Pharmaceutical

SYK - Stryker

LBPSW - 4D pharma

CVS - CVS Health

HCA - HCA Healthcare

ABT - Abbott

TMO - Thermo Fisher Scientific

MDT - Medtronic

TAK - Takeda Pharmaceutical

SYK - Stryker

Frequently Asked Questions